Modified poly(L-lysine)-based structures as novel antimicrobials for diabetic foot infections, an in-vitro study.
收藏资源简介：
<strong>Data used to generate Figures 2 to 7 </strong> Figure 2. Bactericidal activity of poly-L-lysine polymers against <em>S. aureus</em> and <em>P. aeruginosa</em> laboratory strains compared to antibiotics. Figure 3. Bactericidal activity of poly-L-lysine polymers against <em>S. aureus</em> and <em>P. aeruginosa</em> laboratory strains. Figure 4. Comparative bactericidal activity of poly-L-lysine G3(16) copolymers series with hydrophobic amino acid isoleucine, tyrosine and phenylalanine. Figure 5. Comparison of Bactericidal activity of poly-L-lysine polymers, PLL<sub>160 </sub>and G2(8)PLL<sub>20</sub> against <em>S. aureus</em> clinical isolates from wound infections. Figure 6. Bactericidal activity of linear PLL<sub>160 </sub>against <em>S. aureus</em> and <em>P. aeruginosa </em>isolates from suspected diabetic foot infections. Figure 7. Investigation of PLL polymer-induced loss of biofilm viability by resazurin staining of 24 h biofilms.
